Variables in 2011 | Categories | Model A | Model B | Model C | Model D |
---|---|---|---|---|---|
OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | ||
PIM | No | 1 | 1 | 1 | 1 |
Yes | 16.64 (14.28–19.40)* | 16.70 (14.31–19.47)* | 16.01 (13.71–18.70)* | 15.10 (12.91–17.91)* | |
Gender | Women | 1 | 1 | 1 | 1 |
Men | 0.91 (0.78–1.06) | 0.90 (0.77–1.06) | 0.90 (0.77–1.06) | 0.91 (0.77–1.07) | |
Age | 75–79 |  | 1 | 1 | 1 |
80–84 |  | 0.97 (0.82–1.16) | 0.96 (0.81–1.15) | 0.96 (0.80–1.15) | |
85–89 |  | 0.84 (0.68–1.05) | 0.83 (0.66–1.03) | 0.82 (0.66–1.03) | |
≥90 |  | 1.01 (0.75–1.36) | 1.01 (0.75–1.36) | 1.00 (0.74–1.35) | |
Number of chronic conditions | 0 | Â | Â | 1 | 1 |
1 |  |  | 1.24 (0.90–1.70) | 1.23 (0.89–1.69) | |
2–4 |  |  | 1.40 (1.07–1.83)* | 1.36 (1.03–1.78)* | |
5–7 |  |  | 1.52 (1.13–2.04)* | 1.43 (1.06–1.93)* | |
≥8 |  |  | 1.96 (1.38–2.78)* | 1.80 (1.25–2.58)* | |
Polypharmacy | < 5 |  |  |  | 1 |
≥5 |  |  |  | 1.18 (0.99–1.40) |